Bioliberty announced today that it launched its first product, the Lifehub Clinic, as a hub for a portfolio of soft-robotic ...

Zynex (Nasdaq:NYXI) announced today that it submitted its NiCO non-invasive co-oximeter device for FDA 510(k) clearance.

Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX) both face patient lawsuits related to spinal cord stimulation (SCS) ...

GE HealthCare (Nasdaq: GEHC) today unveiled Signa Sprint, an ultra-premium wide-bore 1.5% high-performance gradient MRI ...

Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network created a new medical policy for histotripsy.

Embecta (Nasdaq:EMBC) stock was down today after news of restructuring and mixed second-quarter results. Shares of EMBC were down more than 8% to $12.12 apiece near the close of trading today.

Solventum, spun off from 3M in April 2024, reported $2.1 billion in sales for the first quarter of 2025, an increase of 2.6%.

The Andover, Massachusetts–based medtech company, which offers an organ care system (OCS) for transplant therapy, hit $143.5 ...

Globus Medical stock is down today on an unexpectedly soft Q1 amid an earlier-than-planned integration with recently acquired ...

German medtech giant Siemens Healthineers reduced the lower end of its full-year earnings guidance amid Trump administration ...

SS Innovations plans to submit a de novo classification request to the U.S. FDA for its SSi Mantra 3 surgical robotic system.

Enovis beat earnings expectations in its first quarter 2025 results out today, but the market reaction was tempered.